Interview- the future of antibodies

Laborjournal interview with PROGEN's general manager Dr. Sven Kuhlendahl about recombinant antibodies, antibody quality and trends (in German)

“Before buying 5 cheap antibodies, resulting in 10 failed experiments, an expensive antibody may be a cheaper option in the end!”

Dr. Sven Kuhlendahl explains, how phage display technology may be a solution for antibody generation, not only for therapeutic or diagnostic use but also for the basic research market.

Read the full article (in German) and the interview with Dr. Sven Kuhlendahl, pages 44-50.